Compare SDRL & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SDRL | CMPS |
|---|---|---|
| Founded | 2005 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | 156 |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.0B |
| IPO Year | 2018 | 2020 |
| Metric | SDRL | CMPS |
|---|---|---|
| Price | $47.97 | $13.39 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | ★ $56.00 | $25.38 |
| AVG Volume (30 Days) | 690.6K | ★ 3.5M |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.61 | N/A |
| EPS | ★ 0.36 | N/A |
| Revenue | ★ $1,437,000,000.00 | N/A |
| Revenue This Year | $5.22 | N/A |
| Revenue Next Year | $16.68 | N/A |
| P/E Ratio | $130.58 | ★ N/A |
| Revenue Growth | ★ 3.75 | N/A |
| 52 Week Low | $28.10 | $3.97 |
| 52 Week High | $55.47 | $15.40 |
| Indicator | SDRL | CMPS |
|---|---|---|
| Relative Strength Index (RSI) | 65.38 | 55.78 |
| Support Level | $46.78 | $10.66 |
| Resistance Level | $49.61 | $14.92 |
| Average True Range (ATR) | 1.83 | 0.75 |
| MACD | 0.53 | 0.19 |
| Stochastic Oscillator | 92.26 | 67.62 |
Seadrill Ltd is an offshore drilling contractor company. The company is engaged in providing offshore drilling services to the oil and gas industry. The primary business of the company is the ownership and operation of drillships, semi-submersible rigs, and jack-up rigs for operations in shallow to ultra-deepwater areas in both benign and harsh environments. The geographical segments of the company are the United States, Brazil, Angola, Norway, and others. The company derives maximum revenue from Brazil.
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.